Ascendis Pharma
ASND
ASND
170 hedge funds and large institutions have $7.24B invested in Ascendis Pharma in 2021 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 73 increasing their positions, 51 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
3% less funds holding
Funds holding: 176 → 170 (-6)
15% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 26
78% less call options, than puts
Call options by funds: $15.9M | Put options by funds: $70.9M
Holders
170
Holding in Top 10
9
Calls
$15.9M
Puts
$70.9M
Top Buyers
| 1 | +$250M | |
| 2 | +$55.9M | |
| 3 | +$51.8M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$50.3M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$42.2M |
Top Sellers
| 1 | -$82.2M | |
| 2 | -$66.8M | |
| 3 | -$24.6M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$22.6M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$18.1M |